Duck Viral Enteritis (Duck Plague): Etiology, Epidemiology, and Clinical Management

Introduction

Duck viral enteritis (DVE), commonly known as duck plague, is an acute, highly contagious viral disease affecting ducks, geese, swans, and other waterfowl. The condition is caused by infection with Anatid herpesvirus 1 (AnHV-1), a member of the subfamily Alphaherpesvirinae within the family Herpesviridae [1, 2, 3]. DVE represents a major threat to commercial duck production and wild waterfowl conservation worldwide. The question “what is ducks disease” frequently refers to DVE when sudden mortality and hemorrhagic enteritis are observed in duck flocks. This article provides a systematic review of the etiologic agent, epidemiologic patterns, clinical and pathologic features, diagnostic methods, therapeutic approaches, and control measures for duck plague.

Etiology

Virus Classification and Genomic Organization

Duck enteritis virus (DEV) is a double-stranded DNA virus with a genome length of approximately 150 to 160 kilobase pairs [2, 3, 4]. Complete genome sequences of virulent strains have been determined from various geographic origins, including Bangladesh, China, and the United States [2, 3, 4]. The DEV genome encodes more than 70 open reading frames, many of which are conserved among alphaherpesviruses. Notable functional genes include UL50, UL24, UL14, US3, LORF4, and ICP27 [5, 6, 7, 8, 9, 10]. The UL50 gene product is essential for viral DNA replication and pathogenesis; deletion of UL50 abrogates infectivity in vitro and in vivo [5]. The UL24 protein initiates K48- and K63-linked polyubiquitination of interferon regulatory factor 7 (IRF7), thereby antagonizing the host innate immune response [6]. The US3 protein kinase phosphorylates IRF7 to inhibit DNA sensing via the cGAS-STING pathway [11, 9]. The UL14 protein contributes to virion morphogenesis and replication efficiency [10]. The LORF4 gene is classified as a late gene and is nonessential for in vitro replication [7].

Virus Replication and Cell Biology

DEV replicates productively in duck embryo fibroblasts (DEFs) and chicken embryo fibroblasts (CEFs) [12]. The viral VP26 protein interacts with the host actin-myosin II network to regulate viral proliferation; disruption of this interaction reduces viral titers [13]. Chlorogenic acid has been shown to modulate the transcriptomic response in DEV-infected DEFs, suggesting potential antiviral activity [14]. The virus also utilizes the cellular machinery for encapsidation and egress, processes that depend on UL14 function [10].

Immune Evasion Mechanisms

DEV employs multiple strategies to subvert host antiviral immunity. The US3 kinase phosphorylates IRF7, preventing its nuclear translocation and thereby suppressing interferon induction [9]. The UL24 protein promotes polyubiquitination of IRF7, targeting it for proteasomal degradation [6]. Additionally, DEV inhibits the cGAS-STING DNA-sensing pathway, a critical cytoplasmic surveillance mechanism against DNA viruses [11]. The host innate response is further modulated by alterations in toll-like receptor (TLR) and cytokine gene expression profiles during infection [15].

Epidemiology

Host Range and Susceptibility

DVE primarily affects Anseriformes, including domestic ducks, geese, and swans, as well as many wild waterfowl species. Outbreaks have been documented in commercially farmed ducks, zoo collections, and wild populations. A notable outbreak in Australian black swans (Cygnus atratus) in a safari park in Bangladesh has been described [16]. In the United States, surveillance of game-farm mallards (Anas platyrhynchos) has detected DEV, indicating spillover risk to wild birds [17]. A novel DEV variant derived from geese in China has been characterized with distinct genomic features and pathogenicity profiles [18].

Geographic Distribution and Outbreaks

DEV has a worldwide distribution. Complete genome sequencing of virulent strains from Bangladesh revealed similarity to Chinese isolates [2]. An outbreak in vaccinated duck flocks in China was traced to a virulent strain that overcame vaccine immunity [1]. Novel variants carrying a deletion in the UL2 gene have emerged in China, showing altered pathogenicity and genetic diversity [3, 19]. These variants retain virulence but display distinct molecular signatures [19]. An Indian isolate of DEV has been used to study host gene expression and vaccine development [12, 15].

Transmission Dynamics

Transmission occurs horizontally via the fecal-oral route, through contaminated water, feed, equipment, and fomites. The virus is shed in feces and oropharyngeal secretions. High-density rearing conditions favor rapid spread. Horizontal transmission of DEV-vectored vaccines in one-day-old chickens has been evaluated, revealing tissue tropism but no transmission to sentinel birds [20]. In non-target species, live attenuated DEV vaccines have shown limited transmissibility [21].

Clinical Signs

The incubation period ranges from 3 to 7 days. The disease presents with acute onset of depression, anorexia, polydipsia, and reluctance to move. Ocular and nasal discharges are common [18, 16]. As the disease progresses, birds develop watery to bloody diarrhea, sometimes with mucus. Cloacal hemorrhage is a classic sign. In peracute cases, death occurs within 24 to 48 hours without premonitory signs. Neurologic signs including ataxia, tremors, and paralysis may be observed [16]. Morbidity and mortality vary but can reach 90% in naive populations [1, 18]. In vaccinated but partially protected flocks, milder signs and lower mortality are observed [1].

Pathology

Gross Lesions

Pathognomonic gross lesions include hemorrhagic enteritis, with petechiae and ecchymoses on the serosal surfaces of the gastrointestinal tract, particularly the esophagus, ceca, and rectum. The liver may be enlarged with pale necrotic foci. The spleen is often swollen and mottled. Hemorrhages are also seen on the heart, kidneys, and pancreas. Esophageal and cloacal mucosal hemorrhages with diphtheritic membranes are characteristic [16].

Histopathology

Microscopic examination reveals intranuclear inclusion bodies (Cowdry type A) in hepatocytes, esophageal epithelial cells, and intestinal epithelial cells. Hepatic necrosis with infiltration of mononuclear cells is prominent. Vascular damage with fibrinoid necrosis of small arteries and veins contributes to hemorrhage. The viral infection induces apoptosis in intestinal epithelial cells, and polyinosinic-polycytidylic acid (poly I:C) treatment has been shown to alleviate intestinal injury by inhibiting apoptosis [22].

Diagnostics

Sample Collection and Virus Isolation

Samples should include liver, spleen, intestinal contents, and cloacal swabs from acutely ill or freshly dead birds. Virus isolation can be performed in DEFs or CEFs with observation of cytopathic effect (CPE) characterized by rounding, detachment, and syncytia formation [12]. Embryonated duck eggs are also used for isolation.

Molecular Detection

Polymerase chain reaction (PCR) targeting conserved genes (e.g., UL6, UL2) is widely used. Real-time recombinase polymerase amplification (RPA) has been developed for rapid detection of virulent DEV strains, offering point-of-care applicability with high sensitivity and specificity [23]. Multienzyme isothermal rapid amplification (MIRA) combined with real-time PCR (MIRA-qPCR) and lateral flow dipstick (MIRA-LFD) provides field-deployable detection with visual readout [24]. These methods are particularly valuable for differentiating virulent from vaccine strains [23, 24]. A diagnostic workflow is presented in Figure 1.

flowchart TD
    A[Clinical suspicion: sudden mortality, hemorrhagic enteritis], > B[Sample collection: liver, spleen, cloacal swab]
    B, > C{Screening test}
    C, >|PCR or real-time RPA| D[Positive]
    C, >|Negative| E[Consider other causes: duck hepatitis, fowl cholera, necrotic enteritis]
    D, > F[Confirmatory test: MIRA-LFD or sequencing]
    F, > G[Report diagnosis and initiate control measures]
    F, > H[Submit for genotyping / antimicrobial susceptibility if co-infection suspected]

Serology

Virus neutralization (VN) and enzyme-linked immunosorbent assay (ELISA) are used for serosurveillance and vaccine response monitoring. Commercial ELISA kits are available but not brand-specific.

Advanced Molecular Characterization

Complete genome sequencing using high-throughput sequencers has elucidated genomic diversity and evolutionary relationships [2, 3, 4]. Infectious bacterial artificial chromosome (BAC) clones of virulent DEV strains facilitate reverse genetics and recombinant vaccine construction [4].

Treatment

Supportive Care

No specific antiviral drug is licensed for DVE in waterfowl. Supportive therapy includes electrolyte solutions, vitamins, and broad-spectrum antibiotics to control secondary bacterial infections. Poly I:C has demonstrated beneficial effects in experimental infections by reducing intestinal apoptosis [22].

Experimental Antiviral Compounds

Piperazine, an anthelmintic agent, has shown in vitro activity against AnHV-1 by modulating host cytokine responses, suggesting potential repurposing [25]. Chlorogenic acid, a plant polyphenol, alters the transcriptome of DEV-infected DEFs and warrants in vivo evaluation [14].

Control and Prevention

Vaccination

Live attenuated vaccines are the cornerstone of DVE control in endemic areas. An Indian strain-based vaccine developed in CEF culture has been evaluated for safety and efficacy [12]. Marker vaccines containing a deletion in the ICP27 gene provide robust protection in ducks while allowing serological differentiation of infected from vaccinated animals (DIVA) [8]. Deletion of multiple virulence genes in vaccine strains attenuates intestinal pathogenicity and restores gut microbiota balance [26]. Pathogenicity evaluation of attenuated strains has identified key virulence genes, including UL2 [27, 19].

Recombinant Vector Vaccines

DEV has been engineered as a vector for multivalent vaccines. Recombinant DEV expressing immunogenic genes of duck hepatitis A virus has been constructed [28]. Strains expressing hemagglutinin of influenza virus induce cellular immunity in ducks [29]. The vector has been used to deliver the Cap protein of goose astrovirus [30] and the Pmp17G protein of Chlamydia psittaci using CRISPR/Cas9 editing [31]. Recombinant DEV expressing Pasteurella multocida OmpH confers simultaneous protection against duck plague and fowl cholera [32, 33]. A comprehensive review of recombinant DEV vaccine research has been published [34]. The safety of these vectors in non-target species has been assessed, with limited tissue tropism and no horizontal transmission observed in chickens [20, 21].

Biosecurity

Preventive measures include all-in/all-out management, quarantine of new introductions, disinfection of facilities with virucidal agents, and control of wild waterfowl access to production ponds. Vaccination of breeder and replacement flocks is recommended in endemic regions. Rapid detection using real-time RPA or MIRA assays enables early containment [23, 24].

Conclusions

Duck viral enteritis remains a significant threat to both commercial and wild waterfowl populations. Advances in genomic characterization, rapid molecular diagnostics, and recombinant vaccine technology have improved the ability to detect, differentiate, and control the disease. Continued surveillance for emerging variants and evaluation of novel antiviral compounds are needed to sustain effective management.

References

[1] Sang S, Wang H, Dan Y et al. Isolation, identification and pathogenicity analysis of a virulent duck enteritis virus strain causing outbreak in vaccinated duck flocks. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42322961/

[2] Yasmin L, Siddique MS, Islam T et al. Complete genome sequence of a virulent duck enteritis virus isolated from Northern part of Bangladesh. Microbiol Resour Announc. 2025. https://pubmed.ncbi.nlm.nih.gov/41134219/

[3] Yang H, Zhang B, Yang X et al. Complete genome sequence and biological characteristics of a novel duck enteritis virus variant with a deletion in UL2. Arch Virol. 2025. https://pubmed.ncbi.nlm.nih.gov/40991013/

[4] Huo SX, Zhu YC, Chen L et al. Complete Genome Sequence and Construction of an Infectious Bacterial Artificial Chromosome Clone of a Virulent Duck Enteritis Virus Strain XJ. Transbound Emerg Dis. 2024. https://pubmed.ncbi.nlm.nih.gov/40303036/

[5] Huo SX, Chen L, Bao ED et al. Functional characterization of UL50 gene reveals its essential role in duck enteritis virus replication and pathogenesis. Vet Q. 2026. https://pubmed.ncbi.nlm.nih.gov/41876382/

[6] Ruan P, Chen Y, Wang M et al. Duck plague virus UL24 protein initiates K48/K63-linked IRF7 polyubiquitination to antagonize the innate immune response. Poult Sci. 2024. https://pubmed.ncbi.nlm.nih.gov/39418790/

[7] Huang J, Wang M, Cheng A et al. Duck enteritis virus LORF4 gene is a late gene and nonessential for virus replication in vitro. Poult Sci. 2024. https://pubmed.ncbi.nlm.nih.gov/39288717/

[8] Wu Y, Liu L, Zhang M et al. A Recombinant Duck Plague Virus Containing the ICP27 Deletion Marker Provides Robust Protection in Ducks. Microbiol Spectr. 2023. https://pubmed.ncbi.nlm.nih.gov/37404171/

[9] Liu R, Gao L, Yang F et al. Duck Enteritis Virus Protein Kinase US3 Inhibits DNA Sensing Signaling by Phosphorylating Interferon Regulatory Factor 7. Microbiol Spectr. 2022. https://pubmed.ncbi.nlm.nih.gov/36287016/

[10] Wan J, Li F, Wang M et al. The protein encoded by the duck plague virus UL14 gene regulates virion morphogenesis and affects viral replication. Poult Sci. 2022. https://pubmed.ncbi.nlm.nih.gov/35489250/

[11] Gao L, Liu R, Yang F et al. Duck Enteritis Virus Inhibits the cGAS-STING DNA-Sensing Pathway To Evade the Innate Immune Response. J Virol. 2022. https://pubmed.ncbi.nlm.nih.gov/36448809/

[12] Dandapat S, Bindu S, Sharma GK et al. Development and evaluation of a chicken embryo fibroblast cell culture based live attenuated Indian strain duck plague vaccine. Vet Q. 2024. https://pubmed.ncbi.nlm.nih.gov/38726839/

[13] Chen L, Zhu YC, Yun T et al. Proteomic Screening for Cellular Targets of the Duck Enteritis Virus Protein VP26 Reveals That the Host Actin-Myosin II Network Regulates the Proliferation of the Virus. Int J Mol Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/41009665/

[14] Yang Y, Zhang Q, Cai H et al. RNA-seq analysis of chlorogenic acid intervention in duck embryo fibroblasts infected with duck plague virus. Virol J. 2024. https://pubmed.ncbi.nlm.nih.gov/38454409/

[15] Kumar J, Dandapat S, Panickan S et al. Expression profiles of toll like receptors, MHC and cytokine genes along with viral load in organs of ducklings infected with an Indian isolate of duck enteritis virus. Microb Pathog. 2022. https://pubmed.ncbi.nlm.nih.gov/35339656/

[16] Islam MM, Islam J, Islam MS et al. Duck virus enteritis (duck plague) outbreak in an Australian black swan (Cygnus atratus) flock at safari park in Bangladesh: A case report. J Adv Vet Anim Res. 2021. https://pubmed.ncbi.nlm.nih.gov/35106294/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[17] Bourke BP, Dusek RJ, Ergunay K et al. Viral pathogen detection in U.S. game-farm mallard (Anas platyrhynchos) flags spillover risk to wild birds. Front Vet Sci. 2024. https://pubmed.ncbi.nlm.nih.gov/38860005/

[18] Guo Z, Zhang S, Sun Y et al. Genomic characteristics, pathogenicity and viral shedding of a novel DVEV variant derived from goose. Poult Sci. 2023. https://pubmed.ncbi.nlm.nih.gov/36745957/

[19] Yin D, Gao Y, Xu M et al. Pathogenic mechanisms and molecular features of a novel UL2 gene-deficient duck enteritis virus endemic to China. Virulence. 2025. https://pubmed.ncbi.nlm.nih.gov/40801158/

[20] Abdulrahim Y, You Y, Wang L et al. Evaluation of Tissue Tropism and Horizontal Transmission of a Duck Enteritis Virus Vectored Vaccine in One-Day-Old Chicken. Viruses. 2024. https://pubmed.ncbi.nlm.nih.gov/39599796/

[21] Kong J, Feng K, Zhao Q et al. Pathogenicity and transmissibility studies on live attenuated duck enteritis virus vaccine in non-target species. Front Microbiol. 2022. https://pubmed.ncbi.nlm.nih.gov/36439841/

[22] Zhang Y, Wu Y, Zhang X et al. Poly I: C Alleviated Duck Intestinal Injury Infected with Duck Viral Enteritis by Inhibiting Apoptosis. Curr Microbiol. 2024. https://pubmed.ncbi.nlm.nih.gov/39105989/

[23] Wan J, Zhu Y, Xu X et al. [Development of a rapid detection method for a virulent strain of duck enteritis virus based on real-time fluorescence recombinase polymerase amplification]. Sheng Wu Gong Cheng Xue Bao. 2026. https://pubmed.ncbi.nlm.nih.gov/42009547/

[24] Dai Y, Hu X, Zhong Y et al. Rapid Detection of Duck Enteritis Virus with MIRA, MIRA-qPCR, and MIRA-LFD Assays. Pathogens. 2025. https://pubmed.ncbi.nlm.nih.gov/41156591/

[25] Bhattacharya S, Kumar S. Piperazine inhibits Anatid herpesvirus-1 infection by possible modulation of host cytokines. Microb Pathog. 2025. https://pubmed.ncbi.nlm.nih.gov/40484049/

[26] Kong J, Han C, Shao G et al. Virulence attenuation of intestinal pathogenicity via combined gene deletion in duck enteritis vaccine strain restores gut microbiota balance and enhances safety. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41764962/

[27] Shi X, Zhuang H, Shuo D et al. Pathogenicity Evaluation and Virulence Gene Identification of an Attenuated Duck Enteritis Virus. Microorganisms. 2025. https://pubmed.ncbi.nlm.nih.gov/41304222/

[28] Jia W, Wang A, Wu Z et al. Construction and characterization of recombinant duck enteritis virus expressing duck hepatitis A virus 3 immunogenic genes. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41850054/

[29] Zhao Y, Ma Q, Jiao C et al. Recombinant duck enteritis virus harboring the hemagglutinin genes of influenza virus rapidly induces specific cellular immunity in ducks. J Virol. 2026. https://pubmed.ncbi.nlm.nih.gov/41467842/

[30] Chen L, Zhu Y, Yun T et al. In vitro expression of the goose astrovirus Cap protein delivered with a duck enteritis virus vector. BMC Vet Res. 2025. https://pubmed.ncbi.nlm.nih.gov/40317044/

[31] Liu J, Wang Y, Tang N et al. CRISPR/Cas9-edited duck enteritis virus expressing Pmp17G of Chlamydia psittaci induced protective immunity in ducklings. Pathog Dis. 2024. https://pubmed.ncbi.nlm.nih.gov/39400699/

[32] Apinda N, Muenthaisong A, Chomjit P et al. Simultaneous Protective Immune Responses of Ducks against Duck Plague and Fowl Cholera by Recombinant Duck Enteritis Virus Vector Expressing Pasteurella multocida OmpH Gene. Vaccines (Basel). 2022. https://pubmed.ncbi.nlm.nih.gov/36016245/

[33] Apinda N, Yao Y, Zhang Y et al. CRISPR/Cas9 Editing of Duck Enteritis Virus Genome for the Construction of a Recombinant Vaccine Vector Expressing ompH Gene of Pasteurella multocida in Two Novel Insertion Sites. Vaccines (Basel). 2022. https://pubmed.ncbi.nlm.nih.gov/35632442/

[34] Jia WF, Wang AP, Wu Z et al. Current status of recombinant duck enteritis virus vector vaccine research. Front Vet Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/39974164/

[35] Abdulrahim Y, You Y, Wang L et al. Correction: Abdulrahim et al. Evaluation of Tissue Tropism and Horizontal Transmission of a Duck Enteritis Virus Vectored Vaccine in One-Day-Old Chicken. Viruses 2024, 16, 1681. Viruses. 2024. https://pubmed.ncbi.nlm.nih.gov/39772278/